Edward Rowland Grauch

Edward Rowland Grauch (chief executive) discloses dealings in Blonder Tongue Laboratories Inc to SEC (Form 4). In total, 116 filings cover trades dated from 26 November 2018 to 30 December 2022.

Every open-market trade on record is a purchase: 9 purchases worth €81k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 107 share grants.

The median purchase comes to €2,536. Clusters matter here: 8 out of 9 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 3 January 2023, the filings show a share grant worth €974 in Blonder Tongue Laboratories Inc. The most recent open-market purchase was published on 20 December 2018, 2,865 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.